Medicines pages
- Find information about a medicinePageSearch for medicines allowed to be supplied in Australia, medicine ingredients and safety information.
- How we regulateSectionFind out how to get a medicine or medical device into the ARTG so you can legally sell it in Australia.
More information
Dispose of unwanted medicines
Health professionals
University student education materials
Latest alerts
- Extension to oral cefalexin substitution instrumentMedicine shortage alertsThe substitution instrument for oral cefalexin liquid products has been extended to 30 April 2024. This will assist with timely access for patients using oral cefalexin syrups and suspensions.
- Be alert if you are taking baclofen in high dosesSafety alertsIf you take baclofen, or care for someone who does, it's important to be alert to the risks of overdose. The risks are greater when using high doses for treating alcohol-use disorder.
- GlucaGen HypoKit shortage extended by one monthMedicine shortage alertsGlucaGen HypoKit (glucagon) shortage will be extended by one month to 31 October 2023
Latest articles
- Update to listed medicine ingredients in October 2023NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2023.
- Warnings on supply and advertising of ‘Haytox’News‘Haytox’ has not been approved by the TGA or included in the Australian Register of Therapeutic Goods (ARTG).
- Use caution when prescribing baclofen off labelSafety updatesRecent coronial inquiries have highlighted the need for health professionals to be alert to the well documented risk of overdose with baclofen.
Latest publications
- ACM meeting statement, Meeting 39, 1-2 June 2023Meeting statementsAdvisory Committee on Medicines meeting statement
- ACM meeting statement, Out of Session Meeting, 10 November 2022Meeting statementsAdvisory Committee on Medicines meeting statement
- ACM meeting statement, Meeting 36, 1-2 December 2022Meeting statementsAdvisory Committee on Medicines meeting statement
Latest consultations
- Public consultation on interim decisions to amend the Poisons Standard - ACMS #40 NOVEMBER 2022 (paracetamol)Closed onConsultationThis consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
- Consultation: International harmonisation of ingredient names (IHIN) – Dual labelling transition to sole medicine ingredient namesClosed onConsultationThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.
- Public consultation on interim decisions to amend the Poisons Standard - JUNE ACMS INTERIM DECISIONS FOR PSILOCYBINE AND MDMA 2022Closed onConsultationThis consultation is for interim decisions made in relation to Psilocybine and MDMA proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS).